MENU
AGIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Agios Pharmaceuticals (AGIO) Earnings Date & Reports

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

AGIO is expected to report earnings to rise 12.36% to -200 cents per share on February 12

Agios Pharmaceuticals AGIO Stock Earnings Reports
Q4'25
Est.
$-2.00
Q3'25
Beat
by $0.12
Q2'25
Missed
by $0.12
Q1'25
Beat
by $0.23
Q4'24
Beat
by $0.24
The last earnings report on October 30 showed earnings per share of -177 cents, beating the estimate of -189 cents. With 112.07K shares outstanding, the current market capitalization sits at 2.48B.
View a ticker or compare two or three
AGIO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AGIO showed earnings on October 30, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
88 Sidney Street
Phone
+1 617 649-8600
Employees
386
Web
https://www.agios.com